Triple-negative breast cancer (TNBC) is the most lethal subtype of BC characterized by lack of expression of hormonal estrogen (ER+) and progesterone receptors (PR+) and the human epidermal growth factor receptor 2 (HER2+) receptor (Pal et al., 2011). Here, PGR is linked to triple-negative breast carcinoma.